Invested in Neuromedical, developer of VGuard non-invasive cognitive treatment for Alzheimer's.
Neuromedical is a research and development company committed to creating groundbreaking solutions to address one of the greatest challenges of modern medicine – Alzheimer’s disease
Neuromedical is a research and development company committed to creating groundbreaking solutions to address one of the greatest challenges of modern medicine – Alzheimer’s disease. We specialize in developing innovative methods for treating cognitive impairments, which are a key symptom of the disease and significantly impact the quality of life for patients and their families.